Navigation Links
MGB Biopharma to Present at Bio-Europe 2013
Date:11/4/2013

cular our lead candidate MGB-BP-3 has shown significant antibacterial activity against a range of Gram positive pathogens and we expect to announce further progress with our on-going programs with MGB-BP-3 in the coming months."

Details of the presentation are as follow:

Title: Infectious Diseases Presentation stream: MGB Biopharma Limited

Time: 10.15am

Location: Level 1, Schubert 4

Venue: Messe Wien Exhibition and Congress Center

About MGB Biopharma

MGB Biopharma is developing a truly novel class of anti-infectives. MGB's lead candidate, MGB-BP-3, is a broad spectrum antibacterial which is active against key multi-resistant Gram positive pathogens. The Company has developed an oral formulation of MGB-BP-3 for Clostridium difficile that is ready to enter the clinic, while an IV formulation for a range of Gram positive infections is in late-stage preclinical development.

MGB's anti-infective drug development capabilities are driven by its broad anti-infective platform, which has the potential to generate truly novel compounds active against other infectious diseases such as Gram negative pathogens as well parasites and fungi.

MGB's anti-infectives are based on minor groove binders (MGBs). Minor groove binders have a new mode of action that offers significant advantages over existing anti-infectives, such as being more bactericidal and active against a broad range of drug-resistant bacteria.

MGB has close links with the University of Strathclyde, with exclusive worldwide licence rights to Strathclyde's MGB patents for all fields expect anticancer. The Company intends to work with partners to fully capitalize on the multiple value creating opportunities offered by its broad and novel anti-infectives platform.

The Company was founded in 2010 and is headquartered in Glasgow, Scotland. It is backed by Scotland's
'/>"/>

SOURCE MGB Biopharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
2. PDL BioPharma to Announce Third Quarter 2013 Financial Results on November 6, 2013
3. Regeneron Named Top Employer in the Global Biopharmaceutical Industry for the Second Year in a Row
4. Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
5. Enteris BioPharma and Nordic BioSciences KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris Proprietary Oral Drug Delivery and Manufacturing Platform
6. CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data Standard Released for Public Review
7. Benu BioVentures to Finance Early Biopharmaceutical Clinical Development
8. Therapure Biopharma Inc. wins a 2013 CMO Leadership Award in All 5 Categories: Quality, Reliability, Innovation, Productivity and Regulatory
9. Recently Patented Technology Poised To Disrupt The Plasma Biopharmaceutical Market
10. Life Cycle Management of Biopharmaceuticals, New Life Science Webinar Hosted by Xtalks
11. KBI Biopharma Selects Freeslate’s Biologics Formulation System for Early and Late Stage Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... and SHENZHEN, China ... Solutions Co., LTD, (BGI Tech), a subsidiary of ... the global launch of a new human whole ... platform. This newly offered service includes in-depth bioinformatics ... reduced prices until December 31, 2014. ...
(Date:7/22/2014)... 22, 2014 In chemical and ... increasingly common sight. The rapid rise of TDL ... well- established as a core gas measurement technology, ... made them the gas analyzer technology of choice ... encountered in some processes have limited their application ...
(Date:7/22/2014)... CAMBRIDGE, Mass. , July 22, 2014 /PRNewswire/ ... of $650 million from philanthropist Ted Stanley ... disorders and bringing new treatments based on molecular ... the world. The Stanley commitment ... among the largest for scientific research in general ...
(Date:7/22/2014)... , July 22, 2014  United Therapeutics ... that it will release its second quarter 2014 ... 29, 2014. United Therapeutics will host ... at 9:00 a.m. Eastern Time.  The teleconference is ... 1-970-315-0533.  A rebroadcast of the teleconference will be ...
Breaking Biology Technology:BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 4$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 5$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 6$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 7$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 8$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 9$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 10
... In trying to explain the complexities of the biotech industry ... that it is a long, painstaking and expensive process. What they ... drug discovery and development process shows us the following pathway: ... , , If the patent life of a drug is ...
... Brian Howell, who elevated technology and business coverage at ... lung cancer. He was 53. , ,Before becoming ... was features editor and, previously, national-foreign editor of the ... included reporting and editing stints in Montana, Minnesota and ...
... lot of talk about customers. Calling on customers. Securing ... many years of loose talk about brand building that ... the brand reputation as much as the vendor does. ... two incredible software companies, customers never really went out ...
Cached Biology Technology:The Complexities, Cost of Midwest Biotech Drug Development 2The Complexities, Cost of Midwest Biotech Drug Development 3The Complexities, Cost of Midwest Biotech Drug Development 4Madison Magazine Editor Dies of Lung Cancer 2The Secret of Success: Listen To Customers 2The Secret of Success: Listen To Customers 3
(Date:7/21/2014)... conserve water and save on your utility bill? A ... in the current issue of the journal Environment ... Most Effective Actions U.S. Households Can Take to Curb ... substantially by simple actions such as installing more efficient ... the suggestions may be familiar, the researchers are the ...
(Date:7/21/2014)... 21, 2014 Dysfunction in dopamine signaling profoundly ... in the brain,s prefrontal cortex and may be ... such as schizophrenia, according to UC Irvine scientists. ... brain cells that receive this neurotransmitter showed for ... a variety of behavioral and physiological functions regulated ...
(Date:7/21/2014)... A team of University of California, Riverside Bourns College of ... the grates of a backyard grill reduces by 70 percent ... The one-eighth inch thick steel carbon plate with an insulated ... a slit into the grill to allow the plate to ... by grill manufacturers who could sell new grills with the ...
Breaking Biology News(10 mins):Researchers provide guide to household water conservation 2Researchers provide guide to household water conservation 3UCI researchers find epigenetic tie to neuropsychiatric disorders 2Catching grease to cut grill pollution 2
... Conn. Triceratops and Torosaurus have long been ... discovery traces the giants, family tree further back in time, ... before its more well-known descendants, making it the earliest known ... Titanoceratops after the Greek myth of the Titans, ...
... brightly glowing nanoparticles may soon be used to light ... U.S. Food and Drug Administration (FDA) has approved the first clinical ... time the FDA has approved using an inorganic material in the ... finally puts a federal approval stamp on all the assumptions we ...
... in genes requires cells to process "messenger RNA" molecules before ... It was long believed that this was simply part ... new types of protein but recent work has made it ... And so attention is gradually shifting to asking why ...
Cached Biology News:Newly discovered dinosaur likely father of Triceratops 2'Cornell Dots' that light up cancer cells go into clinical trials 2If junk DNA is useful, why is it not shared more equally? 2
GOAT ANTI PPP2R5B...
... Molecular Probes Fc OxyBURST Green reagent ... Simons of Boston University to permit measurement ... internalization and the subsequent oxidative burst directly ... assay reagent consists of bovine serum albumin ...
anti-dansyl, rabbit IgG fraction *1 mg/mL* Secondary Detection; Anti-Dye and Anti-Hapten Antibodies...
MOUSE ANTI RAT RT1Bu / MOUSE Ia:BIOTIN Immunogen: Rat thymocyte membrane glycoproteins...
Biology Products: